Smith and Nephew, a British front runner in orthopaedic reconstruction have successfully taken over robotic surgical device producers Blue Belt Technologies.
A price was negotiated at $275 million and the move sees Smith and Nephew get a step ahead in the robotics market. Smith and Nephew CEO, Olivier Bohoun is delighted with the move, stating that the acquisition of Blue Belt Technologies will help emerging Smith & Nephew technology products remain competitive.
What are your thoughts on the impact of this merger on the market and your role?
Nicola Lawler, Head of Marketing at Projectus Consulting